89 related articles for article (PubMed ID: 22149207)
1. MLL-ELL fusion gene in two infants with acute monoblastic leukemia and myeloid sarcoma.
De Braekeleer E; Douet-Guilbert N; Meyer C; Morel F; Marschalek R; De Braekeleer M
Leuk Lymphoma; 2012 Jun; 53(6):1222-4. PubMed ID: 22149207
[No Abstract] [Full Text] [Related]
2. [Acute monoblastic leukemia with MLL/AF9 rearrangement which developed 18 months after myeloid sarcoma onset].
Sato Y; Nakazawa A; Kurosawa H; Fukushima K; Okuya M; Hagisawa S; Sugita K; Arisaka O
Rinsho Ketsueki; 2013 Dec; 54(12):2167-70. PubMed ID: 24452147
[TBL] [Abstract][Full Text] [Related]
3. MLL-AF9 rearrangement in myeloid sarcomas involving the breast.
Wu B; Li F; Zou S
Ann Hematol; 2014 Apr; 93(4):709-10. PubMed ID: 23900528
[No Abstract] [Full Text] [Related]
4. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W
Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091
[TBL] [Abstract][Full Text] [Related]
5. ArgBP2, encoding a negative regulator of ABL, is fused to MLL in a case of infant M5 acute myeloid leukemia involving 4q35 and 11q23.
Pession A; Lo Nigro L; Montemurro L; Serravalle S; Fazzina R; Izzi G; Nucifora G; Slany R; Tonelli R
Leukemia; 2006 Jul; 20(7):1310-3. PubMed ID: 16628191
[No Abstract] [Full Text] [Related]
6. The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression.
Fleischmann KK; Pagel P; von Frowein J; Magg T; Roscher AA; Schmid I
J Exp Clin Cancer Res; 2016 Jan; 35():9. PubMed ID: 26762252
[TBL] [Abstract][Full Text] [Related]
7. A complex 1;19;11 translocation involving the MLL gene in a patient with congenital acute monoblastic leukemia identified by molecular and cytogenetic techniques.
De Braekeleer E; Meyer C; Douet-Guilbert N; Morel F; Le Bris MJ; Marschalek R; Férec C; De Braekeleer M
Ann Hematol; 2009 Aug; 88(8):795-7. PubMed ID: 19107484
[No Abstract] [Full Text] [Related]
8. MLL-MLLT10 fusion in acute monoblastic leukemia: variant complex rearrangements and 11q proximal breakpoint heterogeneity.
Morerio C; Rapella A; Rosanda C; Lanino E; Lo Nigro L; Di Cataldo A; Maserati E; Pasquali F; Panarello C
Cancer Genet Cytogenet; 2004 Jul; 152(2):108-12. PubMed ID: 15262427
[TBL] [Abstract][Full Text] [Related]
9. Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin.
Asano H; Yamamoto G; Hosoi M; Takahashi T; Hangaishi A; Kurokawa M
Leuk Res; 2010 Jul; 34(7):e152-3. PubMed ID: 20061019
[No Abstract] [Full Text] [Related]
10. [Refractory primary myeloid sarcoma of the breast with MLL-AF9 rearrangement].
Uchida E; Watanabe K; Oshikawa G; Sakashita C; Kurosu T; Fukuda T; Arai A; Murakami N; Miura O; Yamamoto M
Rinsho Ketsueki; 2016 Jan; 57(1):47-51. PubMed ID: 26861104
[TBL] [Abstract][Full Text] [Related]
11. A novel AF9 breakpoint in MLL-AF9-positive acute monoblastic leukemia.
Alonso CN; Longo PL; Gallego MS; Medina A; Felice MS
Pediatr Blood Cancer; 2008 Apr; 50(4):869-71. PubMed ID: 18000862
[TBL] [Abstract][Full Text] [Related]
12. Myeloid Sarcoma of the Testis in Children: Clinicopathologic and Immunohistochemical Characteristics With KMT2A (MLL) Gene Rearrangement Correlation.
El Jamal SM; Salama A; Marcellino BK; Abulsayen HA; Zhou X; Hassan M; Firpo-Betancourt A; Saad AG
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):501-507. PubMed ID: 31241561
[TBL] [Abstract][Full Text] [Related]
13. Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion gene.
Krumbholz M; Jung R; Bradtke J; Reinhardt D; Stachel D; Metzler M
Leuk Lymphoma; 2015 Mar; 56(3):793-6. PubMed ID: 24884312
[No Abstract] [Full Text] [Related]
14. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
[TBL] [Abstract][Full Text] [Related]
15. [Effect of MLL-AF9 fusion gene silence of acute monocytic leukemia cell line THP-1 on cyclin-dependent kinase inhibitor p27 expression].
Li L; Liu LB; Wang L; Zou P
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):375-8. PubMed ID: 19031738
[TBL] [Abstract][Full Text] [Related]
16. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.
Hinterleitner C; Huelsenbeck J; Henninger C; Wartlick F; Schorr A; Kaina B; Fritz G
Apoptosis; 2013 Aug; 18(8):963-79. PubMed ID: 23624644
[TBL] [Abstract][Full Text] [Related]
17. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract][Full Text] [Related]
18. MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).
Launay E; Henry C; Meyer C; Chappé C; Taque S; Boulland ML; Ben Abdelali R; Dugay F; Marschalek R; Bastard C; Fest T; Gandemer V; Belaud-Rotureau MA
Leuk Lymphoma; 2014 Mar; 55(3):662-7. PubMed ID: 23725386
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.
Muto T; Takeuchi M; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Aotsuka N; Iseki T; Nakaseko C
Int J Hematol; 2015 Jul; 102(1):86-92. PubMed ID: 25758097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
